Changes in HIV and AIDS in the United States: Entering the third decade

Current Infectious Disease Reports

Volumn 7, Issue 2, 2005, Pages 138-143

  Kellerman, Scott ^a   Begley, Elin ^b   Boyett, Brian ^b   Clark, Hollie ^b   Schulden, Jeff ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BLOOD TRANSFUSION; CHILD CARE; CLINICAL TRIAL; DRUG RESEARCH; EARLY DIAGNOSIS; EPIDEMIC; ETHNIC DIFFERENCE; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; INTRAVENOUS DRUG ABUSE; OCCUPATIONAL EXPOSURE; PUBLIC HEALTH; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; SURVIVAL RATE; UNITED STATES; VIRUS TRANSMISSION;

EID: 17044386220     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-005-0074-1     Document Type: Review

References (74)

1. AIDS Epidemic Update. December 2003. UNAIDS. http://www.unaids.org/html/pub/publications/irc-pub06/jc943- epiupdate2003_en_pdf.htm. Accessed June 14, 2004.
2. Centers for Disease Control and Prevention: HIV/AIDS Surveillance Report 2002, 14:1-48.
3. Karon JM, Fleming PL, Steketee RW, DeCock KM: HIV in the United States at the turn of the century: an epidemic in transition. Am J Public Health 2001, 91:1060-1068.
4. Fleming PL, Byers RH, Sweeney PA, et al.: HIV Prevalence in the United States, 2000. Presented at the 9th Conference on Retroviruses and Opportunistic Infections. Seattle, WA, February 24-28, 2002. Abstract 11.
5. Centers for Disease Control and Prevention: Guidelines for national human immunodeficiency virus case surveillance, including monitoring of human immunodeficiency virus infection and acquired immunodeficiency syndrome. MMWR Morb Mortal Wkly Rep 1999, 48:1-31.
6. Hader SL, Smith DK, Moore JS, Holmberg SD: HIV infection in women in the United States: status at the millennium. JAMA 2001, 285:1186-1192.
7. Rosenberg P, Biggar R: Trends in HIV incidence among young adults in the United States. JAMA 1998, 279:1894-1899.
8. Centers for Disease Control and Prevention: HIV/AIDS surveillance supplemental report: Cases of HIV infection and AIDS in the United States, by race/ethnicity. MMWR Morb Mortal Wkly Rep 1998-2002, 10:1-38.
9. Adimora AA, Schoenbach VJ: Contextual factors and the black-white disparity in heterosexual HIV transmission. Epidemiology 2002, 13:707-712.
10. Laumann EO, Youm Y: Racial/ethnic group differences in the prevalence of sexually transmitted diseases in the United States: a network explanation. Sex Transm Dis 1999, 26:250-261.
11. Smith DK, Gwinn M, Selik RM, et al.: HIV/AIDS among African Americans: Progress or progression? AIDS 2000, 14: 237-1248.
12. Morales LS, Cunningham WE, Galvan FH, et al.: Sociodemographic differences in access to care among Hispanic patients who are HIV infected in the United States. Am J Public Health 2004, 94:1118-1121.
13. Catania JA, Osmond D, Stall RD, et al.: The continuing HIV epidemic among men who have sex with men. Am J Public Health 2001, 91:907-914.
14. Harawa NT, Greenland S, Bingham TA, et al.: Associations of race/ethnicity with HIV prevalence and HIV-related behaviors among young men who have sex with men in 7 urban centers in the United States. J Acquir Immune Defic Syndr 2004, 35: 26-536.
15. Fleming P, Ward J, Karon J, et al.: Declines in AIDS incidence and deaths in the USA: a signal change in the epidemic. AIDS 1998, 12(Suppl A):S55-S61.
16. Palella F Jr, Delaney K, Moorman A, et al.: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998, 338:853-860.
17. Savin CA: The changing clinical epidemiology of AIDS in the highly active antiretroviral therapy era. AIDS 2002, 16(Suppl 4):S61-S68.
18. Fischl M, Richman D, Grieco M, et al.: The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med 1987, 317:185-191.
19. Kitchen V, Skinner C, Ariyoshi K, et al.: Safety and activity of saquinavir in HIV infection. Lancet 1995, 345: 52-955.
20. Carr A, Samaras K, Chisholm DJ, Cooper DA: Pathogenesis of HIV-1 protease inhibitor associated peripheral lipodystrophy, hyperlipidemia, and insulin resistance. Lancet 1998, 351: 881-1883.
21. Tebas P, Powderly WG, Claxton S, et al.: Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy. AIDS 2000, 14:F63-F67.
22. Sulkowski M, Thomas D, Chaisson R, Moore R: Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection. JAMA 2000, 283:74-80.
23. Selik RM, Byers RH, Dworkin MS: Trends in diseases reported on U.S. death certificates that mentioned HIV infection, 1987-1999. J Acquir Immune Defic Syndr 2002, 29:378-387.
24. Chiao EY, Krown SE: Update on non-acquired immunodeficiency syndrome-defining malignancies. Curr Opin Oncol 2003, 15:389-397.
25. Selik RM, Rabkin CS: Cancer death rates associated with human immunodeficiency virus infection in the United States. J Natl Cancer Inst 1998, 90:1300-1302.
26. Sullivan P, Chu S, Fleming P, Ward J: Changes in AIDS incidence for men whi have sex with men, United States 1990-1995. AIDS 1997, 11:1641-1646.
27. Denning PH, Jones JL, Ward J: Recent trends in the HIV epidemic in adolescent and young adult gay and bisexual men. J Acquir Immune Defic Syndr Hum Retrovirol 1997, 16:374-379.
28. Katz M, McFarland W, Guillin V, et al.: Continuing high prevalence of HIV and risk behaviors among young men who have sex with men: the young men's survey in the San Francisco Bay Area in 1992 to 1993 and in 1994 to 1995. J Acquir Immune Defic Syndr Retrovirol 1998, 19:178-181.
29. Centers for Disease Control and Prevention: HIV/AIDS among men of color who have sex with men-United States, January 1989-December 1998. MMWR Morb Mortal Wkly Rep 2000, 49:4-11.
30. Ekstrand M, Stall R, Paul J, et al.: Gay men report high rates of unprotected anal sex with partners of unknown or discordant HIV status. AIDS 1999, 13:1525-1533.
31. Suarez TP, Kelly JA, Pinkerton SD, et al.: Influence of a partner's HIV serostatus, use of highly active antiretroviral therapy, and a viral load on perceptions of sexual risk behavior in a community sample of men who have sex with men. J Acquir Immune Defic Syndr 2001, 28:471-477.
32. Stockman JD, Schwarcz SK, Butler LM, et al.: HIV prevention fatigue among high-risk populations in San Francisco. J Acquir Immune Defic Syndr 2004, 35:432-434.
33. McFarland W, Kellogg TA, Dilley J, Katz MH: Estimation of human immunodeficiency virus (HIV) seroincidence among repeat anonymous testers in San Francisco. Am J Epidemiol 1997, 146: 62-664.
34. Kellogg T, McFarland W, Katz M: Recent increases in HIV seroconversion among repeat anonymous testers in San Francisco [letter]. AIDS 1999, 13:2303-2304.
35. Wolitski, RJ, Valdiserri RO, Denning PH, Levine WC: Are we headed for a resurgence of the HIV epidemic among men who have sex with men? Am J Public Health 2001, 91:883-888.
36. Centers for Disease Control and Prevention: Resurgent bacterial sexually transmitted disease among men who have sex with men, King County, Washington, 1997-1999. MMWR Morb Mortal Wkly Rep. 1999, 48:773-777.
37. Centers for Disease Control and Prevention: Increases in unsafe sex and rectal gonorrhea among men who have sex with men, San Francisco, California, 1994-1997. MMWR Morb Mortal Wkly Rep. 1999, 48:45-48.
38. Do AN, Hanson DL, Dworkin MS, et al.: Risk factors for and trends in gonorrhea incidence among persons infected with HIV in the United States. AIDS 2001, 15:1149-1155.
39. Centers for Disease Control and Prevention: HIV prevention through early detection and treatment of sexually transmitted disease - United State. MMWR Morb Mortal Wkly Rep 1998, 47:1-31.
40. Adams AL, Becker TM, Lapidus JA, et al.: HIV infection risk, behaviors, and attitudes about testing: are perceptions changing? Sex Transm Dis 2003, 30:764-768.
41. Des Jarlais D, Friedman SR: Fifteen years of research on preventing HIV infection among injecting drug users: what we have learned, what we have not learned, what we have done, what we have not done. Public Health Rep 1998, 113(Suppl 1):182-188.
42. Des Jarlais D, Hagan H, Friedman SR: Maintaining low HIV seroprevalence in populations of injecting drug users. JAMA 1995, 274:1226-1231.
43. Des Jarlais D, Friedman SR, Perlis T, et al.: Risk behavior and HIV infection among new drug injectors in the era of AIDS in New York City. J Acquir Immune Defic Syndr Hum Retrovirol 1999, 20:67-72.
44. Centers for Disease Control and Prevention: National HIV prevalence surveys, 1997 summary. Atlanta: Division of HIV/AIDS Prevention-Surveillance and Epidemiology, National Center for HIV, STD, and TB Prevention, CDC; 1998:1-25.
45. Des Jarlais DC, Marmor M, Friedmann P, et al.: HIV incidence among injection drug users in New York City, 1992-1997:evidence for a declining epidemic. Am J Public Health 2000, 90: 52-359.
46. Centers for Disease Control and Prevention: HIV diagnoses among injection-drug users in the states with HIV surveillance-25 states, 1994-2000. MMWR Morb Mort Wkly Rep 2003, 52:634-636.
47. Community Epidemiology Work Group (CEWG), National Institutes of Health, National Institute on Drug Abuse: Drug abuse highlights for the United States. http://www.cdmgroup.com/cewg/pubs.htm. Accessed June 15, 2004.
48. Klevens R, Fleming P, Neal J, Li J: Is there really a heterosexual AIDS epidemic in the United States? Findings from a multisite validation study, 1992-1995. Mode of Transmission Validation Study Group. Am J Epidemiol 1999, 149:75-84.
49. Chakrabory H, Sen PK, Helms RW, et al.: Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: A probabilistic empiric model. AIDS 2001, 15: 21-627.
50. DeCock KM, Weiss HA: The global epidemiology of HIV/AIDS. Trop Med Int Health 2000, 5:A3-A9.
51. Quinn TC, Wawer MJ, Sewankambo N, et al.: Viral load and heterosexual transmission of human immunodeficiency virus type 1. N Engl J Med 2000, 342:921-929.
52. Royce R, Sena M, Cates W, Cohen M: Sexual transmission of HIV. N Engl J Med 1997, 336:1072-1078. [Published erratum appears in N Engl J Med 1997, 337:799.]
53. Padian N, Shiboski S, Glass S, Vittinghoff E. Heterosexual transmission of human immunodeficiency virus (HIV) in northern California: results of a ten-year study. Am J Epidemiol 1997, 146:350-357.
54. Ehrhardt AA, Exner TM: Prevention of sexual risk behavior for HIV infection with women. AIDS 2000, 14(Suppl 2): S53-S58.
55. Garcia-Moreno C, Watts C: Violence against women: its importance for HIV/AIDS. AIDS 2000, 14(Suppl 2): S53-S65.
56. Cooper ER, Charurat M, Mofensen L, et al.: Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr, 2002, 29:484-494.
57. Mofensen LW: Successes and challenges in the perinatal HIV-1 epedemic in the United States as illustrated by the HIV-1 serosurvey of childbearing women. Arch Pediatr Adolesc Med 2004, 158:422-425.
58. Dorenbaum A, Cunningham CK, Gelber RD, et al.: Two-dose intrapartum/newborn nervirapine and standard antiretroviral therapy to reduce perinatal HIV-1 transmission: a randomized trial. JAMA 2002, 288:189-198.
59. Bulterys M, Jamieson DJ, O'Sullivan MJ, et al.: Rapid HIV-1 testing during labor: a multicenter study. JAMA 2004, 292:219-223.
60. Cunningham C, Balasubramanian R, Delke I, et al.: The impact of race/ethnicity on mother-to-child HIV transmission in the United States in pediatric AIDS clinical trials group protocol 316. J Acquire Immune Defic Syndr 2004, 36:800-807.
61. Do AN, Ciesielski CA, Metler RP, et al.: Occupationally acquired human immunodeficiency virus (HIV) infection: national case surveillance data during 20 years of the HIV epidemic in the United States. Infect Control Hosp Epidemiol 2003, 24: 6-96.
62. Alvarado-Ramy F, Beltrami EM: New guidelines for occupational exposure to blood-borne viruses. Cleve Clin J Med 2003, 70:457-465.
63. Goodnough LT, Shander A, Brecher ME: Transfusion medicine: looking to the future. Lancet 2003, 361:161-169.
64. Busch MP, Kleinman SH, Jackson B, et al.: Nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases: report of the Interorganizational Task Force on Nucleic Acid Amplification. Transfusion 2000, 40:143-159.
65. Pretty IA, Anderson GS, Sweet DJ: Human bites and the risk of human immunodeficiency virus transmission. Am J Forensic Med Pathol 1999, 20:232-239.
66. Mast EE, Goddman RA, Bond WW, et al.: Transmission of bloodborne pathogens during sports: risk and prevention. Ann Intern Med 1995, 122:28-35.
67. Lindegren M, Hanson I, Hammett T, et al.: Sexual abuse of children: intersection with the HIV epidemic. Pediatrics 1998, 102:E46.
68. Kellerman SE, Do A, Metler R, et al.: Intentional self-inoculation with HIV-positive blood: a case series from the Centers for Disease Control and Prevention HIV/AIDS Surveillance System. AIDS 2004, 18:965-968.
69. Chang ML, Vitek C, Esparza J: WHO-UNAIDS Vaccine Initiative: public health considerations for the use of a first generation HIV vaccine. Report from a WHO-UNAIDS-CDC consultation, Geneva, 20-21 November 2002. AIDS 2003, 17:W1-W10.
70. Calarota SA, Weiner DB: Present status of human HIV vaccine development. AIDS 2003, 17(Suppl 4):S73-S84.
71. Vastag B: HIV vaccine efforts inch forward. JAMA 2001, 286:1826-1828.
72. Frey S: HIV vaccines. Infect Dis Clin North Am 1999, 13:95-112.
73. Janssen RS, Satten GA, Stramer SL, et al.: New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA 1998, 280:42-48. [Published erratum appears in JAMA 1999, 281: 893.]
74. Centers for Disease Control and Prevention: Advancing HIV prevention: new strategies for a changing epidemic-United States. MMWR Morb Mortal Wkly Rep 2003, 452:329-332.